Przeglądaj według tematu "immunotherapy"

Wyświetlanie pozycji 1-2 z 2

    • Attempting to identify bacterial allies in immunotherapy of NSCLC patients 

      Grenda, Anna; Iwan, Ewelina; Krawczyk, Paweł; Frąk, Małgorzata; Chmielewska, Izabela; Bomba, Arkadiusz; Giza, Aleksandra; Rolska-Kopińska, Anna; Szczyrek, Michał; Kieszko, Robert; Kucharczyk, Tomasz; Jarosz, Bożena; Wasyl, Dariusz; Milanowski, Janusz (MDPI, 2022)
      Introduction: Factors other than PD-L1 (Programmed Death Ligand 1) are being sought as predictors for cancer immuno- or chemoimmunotherapy in ongoing studies and long-term ob- servations. Despite high PD-L1 expression ...

    • Gut resistome of NSCLC patients treated with immunotherapy 

      Iwan, Ewelina; Grenda, Anna; Bomba, Arkadiusz; Bielińska, Katarzyna; Wasyl, Dariusz; Kieszko, Robert; Rolska-Kopińska, Anna; Chmielewska, Izabela; Krawczyk, Paweł; Rybczyńska-Tkaczyk, Kamila; Olejnik, Małgorzata; Milanowski, Janusz (Frontiers, 2024)
      Background: The newest method of treatment for patients with NSCLC (non-small cell lung cancer) is immunotherapy directed at the immune checkpoints PD-1 (Programmed Cell Death 1) and PD-L1 (Programmed Cell Death Ligand 1). ...